Tissue Regenix to feature via Discovery Channel
21 July 2016 - 8:09PM
Business Wire
Tissue Regenix Group (AIM:TRX) (“Tissue Regenix” or “The Group”)
the regenerative medical devices company will be featured on an
upcoming episode of Innovations with Ed Begley Jr., airing via the
Discovery Channel on Thursday 21 July at 7:30aET/7:30aPT.
The show will travel to Curitiba, Brazil to see how Tissue
Regenix unique dCELL® technology is transforming the lives of heart
valve patients, with over 1,600 operations now undertaken.
‘Innovations’ will hear from both the patients who have received
the dCELL® valves, and Dr Francisco da Costa who is pioneering the
treatment in Curitiba, where dCELL® valves have now set the
benchmark for treatment.
Antony Odell, CEO Tissue Regenix Group commented: “We are very
proud of the cardiac research work that has been undertaken in
Brazil over the last 10 years. Innovations is an opportunity for us
to showcase the life changing potential of our cutting edge dCELL®
technology, particularly the heart valves”
dCELL® technology is a gentle process which removes DNA and
cellular material from donor tissues. This leaves intact an
acellular matrix upon which the patient’s own cells can repopulate,
regenerating native tissue which will not be rejected by the
body.
Tissue Regenix has applied dCELL® technology to wound care,
orthopaedic sports medicine and cardiac applications, it is
expected that the first dCELL® heart valves will also be available
in Europe during 2017.
About Tissue Regenix
Tissue Regenix is a leading medical devices company in the field
of regenerative medicine. The company's patented decellularisation
('dCELL®') technology removes DNA and other cellular material from
animal and human tissue leaving an acellular tissue scaffold which
is not rejected by the patient's body which can then be used to
repair diseased or worn out body parts. The potential applications
of this process are diverse and address many critical clinical
needs such as vascular disease, heart valve replacement and knee
repair.
Tissue Regenix was formed in 2006 when it was spun-out from the
University of Leeds. The company commercialises academic research
conducted by our partners around the World.
In November 2012 Tissue Regenix Group plc set up a subsidiary
company in the United States - 'Tissue Regenix Wound Care Inc.', as
part of its commercialisation strategy for its dCELL® technology
platform.
About Innovations & DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an
information-based series geared toward educating the public on the
latest breakthroughs in all areas of society. Featuring practical
solutions and important issues facing consumers and professionals
alike, Innovations focuses on cutting-edge advancements in
everything from health and wellness to global business, renewable
energy, and more.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160721005529/en/
Tissue Regenix Group plcCaitlin PearsonCorporate Communications
OfficerTel: 0330 430 3073
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Apr 2024 to May 2024
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From May 2023 to May 2024